Invex Therapeutics Ltd has released a press release.
Invex Receives UK Approval to Commence Phase III Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Invex Therapeutics Ltd. on 6ix
Story so far
Earlier from Invex Therapeutics
- Half Yearly Report and Accounts
- New Executive Director and Chairman Agreements
- Appointment IIH EVOLVE Phase III Trial Steering Group Chair
- Invex Therapeutics: Chairman's Address to Shareholders at AGM
- Global Phase 3 Trial of Presendin to Launch in Q4 2021
Later from Invex Therapeutics
- HREC and TGA Approval to Commence Phase 3 in Australia
- Quarterly Activities/Appendix 4C Cash Flow Report
- Invex receives IND approval
- 4E and Annual Report to shareholders
- Second HREC Approval for IIH EVOLVE Phase III Clinical Trial
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics